Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
2.11 USD
-2.31%
Market Closed
Updated:
May 4, 2024
Compugen Ltd
Research & Development
|
Compugen Ltd
Research & Development Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Research & Development
-$34.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-14%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Research & Development
-$3.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Research & Development
-₪4.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
See Also
What is Compugen Ltd's Research & Development?
Research & Development
-34.5m
USD
-34.5m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Research & Development amounts to -34.5m USD.
What is Compugen Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-14%
-14%
Over the last year, the Research & Development growth was -12%. The average annual Research & Development growth rates for Compugen Ltd have been -15% over the past three years , -3% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
